[go: up one dir, main page]

CN103356968A - Traditional Chinese medicine composition for treating endometriosis - Google Patents

Traditional Chinese medicine composition for treating endometriosis Download PDF

Info

Publication number
CN103356968A
CN103356968A CN2013103282096A CN201310328209A CN103356968A CN 103356968 A CN103356968 A CN 103356968A CN 2013103282096 A CN2013103282096 A CN 2013103282096A CN 201310328209 A CN201310328209 A CN 201310328209A CN 103356968 A CN103356968 A CN 103356968A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013103282096A
Other languages
Chinese (zh)
Other versions
CN103356968B (en
Inventor
黄淑娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nan Lingyan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310328209.6A priority Critical patent/CN103356968B/en
Publication of CN103356968A publication Critical patent/CN103356968A/en
Application granted granted Critical
Publication of CN103356968B publication Critical patent/CN103356968B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating endometriosis. The composition is prepared from the following raw materials, by weight, 12-18 parts of salvia miltiorrhiza, 12-18 parts of radix astragali, 12-18 parts of motherwort, 12-18 parts of spatholobus stems, 9-15 parts of Chinese angelica, 9-15 parts of red peony roots, 9-15 parts of rhizoma sparganii, 9-15 parts of curcuma zedoary, 9-15 parts of curculigo orchioides, 9-15 parts of prepared rehmannia roots, 9-15 parts of fructus Lycii, 6-12 parts of medicinal cyathula roots, 6-12 parts of corydalis tuber, 6-12 parts of sappan wood, 6-12 parts of fluoritum, 6-12 parts of tree peony bark, 6-12 parts of peach kernels, 6-12 parts of banksia rose, 6-12 parts of safflowers, 6-12 parts of radix curcumae, 3-9 parts of ligusticum wallichii and 3-9 parts of myrrh. The traditional Chinese medicine composition has advantages of stable curative effects and no side effects.

Description

A kind of Chinese medicine composition for the treatment of endometriosis
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of endometriosis.
Background technology
Endometriosis refers to when the endometrial tissue with growth function appears at other positions beyond the cavity of uterus lining mucosa.Endometriosis is hormone-dependent diseases, therefore is mainly seen in the women of child-bearing age.In recent years, its sickness rate is more and more higher, has become common gynecological disease, has had a strong impact on numerous women's physical and mental health, brings inconvenience for work, life.
At present, the medicine for the treatment of endometriosis is more, but has the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of endometriosis, the advantage that the present invention has stable curative effect, has no side effect.
A kind of Chinese medicine composition for the treatment of endometriosis is made by the crude drug of following weight portion: Radix Salviae Miltiorrhizae 12-18 part, Radix Astragali 12-18 part, Herba Leonuri 12-18 part, Caulis Spatholobi 12-18 part, Radix Angelicae Sinensis 9-15 part, Radix Paeoniae Rubra 9-15 part, rhizoma sparganic 9-15 part, Rhizoma Curcumae 9-15 part, Rhizoma Curculiginis 9-15 part, Radix Rehmanniae Preparata 9-15 part, Fructus Lycii 9-15 part, Radix Cyathulae 6-12 part, Rhizoma Corydalis 6-12 part, Lignum Sappan 6-12 part, Fluoritum 6-12 part, Cortex Moutan 6-12 part, Semen Persicae 6-12 part, Radix Aucklandiae 6-12 part, Flos Carthami 6-12 part, Radix Curcumae 6-12 part, Rhizoma Chuanxiong 3-9 part, Myrrha 3-9 part.
The Chinese medicine composition of described treatment endometriosis, it is preferably made by the crude drug of following weight portion: 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of the Radixs Astragali, 15 parts of Herba Leonuris, 15 parts of Caulis Spatholobis, 12 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 12 parts of rhizoma sparganic, 12 parts of Rhizoma Curcumae, 12 parts of Rhizoma Curculiginises, 12 parts of Radix Rehmanniae Preparata, 12 parts of Fructus Lycii, 9 parts of Radix Cyathulaes, 9 parts of Rhizoma Corydalis, 9 parts of Lignum Sappans, 9 parts of Fluoritum, 9 parts of Cortex Moutans, 9 parts in Semen Persicae, 9 parts of the Radix Aucklandiae, 9 parts on Flos Carthami, 9 parts of Radix Curcumaes, 6 parts of Rhizoma Chuanxiongs, 6 parts of Myrrhas.
The preparation method of the Chinese medicine composition of described treatment endometriosis is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment endometriosis in preparation treatment endometriosis medicine.
The beneficial effect that the present invention compared with prior art has is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, choose each crude drug and proportioning thereof, function with the liver and the kidney tonifying, blood circulation promoting and blood stasis dispelling, loose Yu Xiao wei, the purpose of realization treatment endometriosis.
Below in conjunction with clinical experiment beneficial effect of the present invention is described:
(1) clinical data: the present invention treats endometriosis patients 45 examples altogether, and the age is 27-51 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., take decoction as example, take 1 pair of every day minutes for 2 times, and early, respectively take 1 time evening, 15 days is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: transference cure, lab testing is normal;
Take a turn for the better: symptom is obviously improved, and lab testing is improved;
Do not heal: primary symptom is not improved, and lab testing does not improve.
(4) therapeutic outcome: the present invention treats endometriosis patients 45 examples altogether, through 1-3 course of therapy, cures 36 examples, accounts for 80%, and 7 examples that take a turn for the better account for 15.6%, and 2 examples that do not heal account for 4.4%, and effective percentage is 95.6%, has no any side effect; Cure in 36 examples, cure 9 examples 1 course for the treatment of, cure 16 examples 2 courses for the treatment of, cure 11 examples 3 courses for the treatment of, follows up a case by regular visits to half after the healing by 1 year, is showed no recurrence; The result shows, the advantage that the present invention has stable curative effect, has no side effect.
The specific embodiment
Embodiment 1:
A kind of Chinese medicine composition for the treatment of endometriosis is made by the crude drug of following weight portion: 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of the Radixs Astragali, 15 parts of Herba Leonuris, 15 parts of Caulis Spatholobis, 12 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 12 parts of rhizoma sparganic, 12 parts of Rhizoma Curcumae, 12 parts of Rhizoma Curculiginises, 12 parts of Radix Rehmanniae Preparata, 12 parts of Fructus Lycii, 9 parts of Radix Cyathulaes, 9 parts of Rhizoma Corydalis, 9 parts of Lignum Sappans, 9 parts of Fluoritum, 9 parts of Cortex Moutans, 9 parts in Semen Persicae, 9 parts of the Radix Aucklandiae, 9 parts on Flos Carthami, 9 parts of Radix Curcumaes, 6 parts of Rhizoma Chuanxiongs, 6 parts of Myrrhas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
A kind of Chinese medicine composition for the treatment of endometriosis is made by the crude drug of following weight portion: 12 parts of Radix Salviae Miltiorrhizaes, 12 parts of the Radixs Astragali, 12 parts of Herba Leonuris, 12 parts of Caulis Spatholobis, 9 parts of Radix Angelicae Sinensis, 9 parts of Radix Paeoniae Rubra, 9 parts of rhizoma sparganic, 9 parts of Rhizoma Curcumae, 9 parts of Rhizoma Curculiginises, 9 parts of Radix Rehmanniae Preparata, 9 parts of Fructus Lycii, 6 parts of Radix Cyathulaes, 6 parts of Rhizoma Corydalis, 6 parts of Lignum Sappans, 6 parts of Fluoritum, 6 parts of Cortex Moutans, 6 parts in Semen Persicae, 6 parts of the Radix Aucklandiae, 6 parts on Flos Carthami, 6 parts of Radix Curcumaes, 3 parts of Rhizoma Chuanxiongs, 3 parts of Myrrhas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
A kind of Chinese medicine composition for the treatment of endometriosis is made by the crude drug of following weight portion: 18 parts of Radix Salviae Miltiorrhizaes, 18 parts of the Radixs Astragali, 18 parts of Herba Leonuris, 18 parts of Caulis Spatholobis, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Paeoniae Rubra, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 15 parts of Rhizoma Curculiginises, 15 parts of Radix Rehmanniae Preparata, 15 parts of Fructus Lycii, 12 parts of Radix Cyathulaes, 12 parts of Rhizoma Corydalis, 12 parts of Lignum Sappans, 12 parts of Fluoritum, 12 parts of Cortex Moutans, 12 parts in Semen Persicae, 12 parts of the Radix Aucklandiae, 12 parts on Flos Carthami, 12 parts of Radix Curcumaes, 9 parts of Rhizoma Chuanxiongs, 9 parts of Myrrhas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.

Claims (4)

1. Chinese medicine composition for the treatment of endometriosis, it is characterized in that: the crude drug by following weight portion is made: Radix Salviae Miltiorrhizae 12-18 part, Radix Astragali 12-18 part, Herba Leonuri 12-18 part, Caulis Spatholobi 12-18 part, Radix Angelicae Sinensis 9-15 part, Radix Paeoniae Rubra 9-15 part, rhizoma sparganic 9-15 part, Rhizoma Curcumae 9-15 part, Rhizoma Curculiginis 9-15 part, Radix Rehmanniae Preparata 9-15 part, Fructus Lycii 9-15 part, Radix Cyathulae 6-12 part, Rhizoma Corydalis 6-12 part, Lignum Sappan 6-12 part, Fluoritum 6-12 part, Cortex Moutan 6-12 part, Semen Persicae 6-12 part, Radix Aucklandiae 6-12 part, Flos Carthami 6-12 part, Radix Curcumae 6-12 part, Rhizoma Chuanxiong 3-9 part, Myrrha 3-9 part.
2. the Chinese medicine composition for the treatment of endometriosis according to claim 1, it is characterized in that: the crude drug by following weight portion is made: 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of the Radixs Astragali, 15 parts of Herba Leonuris, 15 parts of Caulis Spatholobis, 12 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 12 parts of rhizoma sparganic, 12 parts of Rhizoma Curcumae, 12 parts of Rhizoma Curculiginises, 12 parts of Radix Rehmanniae Preparata, 12 parts of Fructus Lycii, 9 parts of Radix Cyathulaes, 9 parts of Rhizoma Corydalis, 9 parts of Lignum Sappans, 9 parts of Fluoritum, 9 parts of Cortex Moutans, 9 parts in Semen Persicae, 9 parts of the Radix Aucklandiae, 9 parts on Flos Carthami, 9 parts of Radix Curcumaes, 6 parts of Rhizoma Chuanxiongs, 6 parts of Myrrhas.
3. the preparation method of the Chinese medicine composition for the treatment of endometriosis according to claim 1 and 2, it is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of endometriosis according to claim 1 and 2 in preparation treatment endometriosis medicine.
CN201310328209.6A 2013-07-31 2013-07-31 Traditional Chinese medicine composition for treating endometriosis Expired - Fee Related CN103356968B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310328209.6A CN103356968B (en) 2013-07-31 2013-07-31 Traditional Chinese medicine composition for treating endometriosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310328209.6A CN103356968B (en) 2013-07-31 2013-07-31 Traditional Chinese medicine composition for treating endometriosis

Publications (2)

Publication Number Publication Date
CN103356968A true CN103356968A (en) 2013-10-23
CN103356968B CN103356968B (en) 2015-01-21

Family

ID=49359770

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310328209.6A Expired - Fee Related CN103356968B (en) 2013-07-31 2013-07-31 Traditional Chinese medicine composition for treating endometriosis

Country Status (1)

Country Link
CN (1) CN103356968B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104288697A (en) * 2014-10-24 2015-01-21 山东省立医院 Traditional Chinese medicine for clearing embryonic tissues and preparation method and application thereof
CN105250925A (en) * 2015-11-13 2016-01-20 王平平 Medicine for treating endometriosis
CN107375883A (en) * 2017-08-10 2017-11-24 丁志红 A kind of semifluid extract of deer foetus for treating infertility, endometriosis and dysmenorrhoea
CN109125041A (en) * 2017-06-19 2019-01-04 龙启安 One seed sand jade treats dedicated sand of magnetic energy and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185333A (en) * 1996-12-20 1998-06-24 许其宽 Womb-warming proconceptive powder

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185333A (en) * 1996-12-20 1998-06-24 许其宽 Womb-warming proconceptive powder

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
刘俊波: "补气止痛汤配合内异贴治疗子宫内膜异位症痛经的临床观察", 《中国优秀硕士学位论文全文数据库.医药卫生科技辑》 *
廖云霞;等: "中药治疗子宫内膜异位症的临床研究进展", 《北京中医药大学学报(中医临床版)》 *
胡蔚洁: "温肾化瘀法治疗子宫内膜异位症60例", 《辽宁中医杂志》 *
郭雯雯;等: "子宫内膜异位症相关古籍证候要素及应证组合研究", 《新中医》 *
高玉敏;等: "黎烈荣治疗子宫内膜异位症经验", 《湖北中医杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104288697A (en) * 2014-10-24 2015-01-21 山东省立医院 Traditional Chinese medicine for clearing embryonic tissues and preparation method and application thereof
CN105250925A (en) * 2015-11-13 2016-01-20 王平平 Medicine for treating endometriosis
CN109125041A (en) * 2017-06-19 2019-01-04 龙启安 One seed sand jade treats dedicated sand of magnetic energy and preparation method thereof
CN107375883A (en) * 2017-08-10 2017-11-24 丁志红 A kind of semifluid extract of deer foetus for treating infertility, endometriosis and dysmenorrhoea

Also Published As

Publication number Publication date
CN103356968B (en) 2015-01-21

Similar Documents

Publication Publication Date Title
CN103356961B (en) Traditional Chinese medicinal composition for treating amenorrhoea
CN103386086A (en) Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof
CN103316174B (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN103393913B (en) Chinese medicinal composition for treating uterine prolapse
CN103330920B (en) Traditional Chinese medicine composition for curing oviduct obstruction
CN102188583A (en) Traditional Chinese medicine for treating infertility
CN103356968B (en) Traditional Chinese medicine composition for treating endometriosis
CN103393966A (en) Chinese medicinal composition for treating irregular menstruation
CN103800843A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammation
CN103446554A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN104645146A (en) Chinese medicine composition for treating acne
CN103356969A (en) Traditional Chinese medicine composition for treating hysteromyoma
CN103784793A (en) Traditional Chinese medicine for treating climacteric syndrome
CN103845620A (en) Traditional Chinese medicine for treating raynaud disease
CN104435252A (en) Medicine for treating acute mastitis
CN103550679A (en) Traditional Chinese medicine formula for treatment of lithangiuria
CN103349759A (en) Traditional Chinese medicine composition for treating ovarian cyst
CN101926880A (en) Chinese medicinal composition for treating amenorrhea and endometritis of women
CN103356963B (en) Traditional Chinese medicine composition for treating infertility
CN104587385A (en) Traditional Chinese medicine composition for treating blood stasis condensation type rosacea
CN104274603A (en) Traditional Chinese medicine for treating leg cramps
CN104162043A (en) Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis
CN103800664A (en) Traditional Chinese medicine composition for treating menopausal syndrome
CN105343803A (en) Traditional Chinese medicine ointment for treating gynecological inflammation
CN104800599A (en) Traditional Chinese medicinal composition for treating deficiency of kidney-yin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Nan Lingyan

Inventor after: Guo Yuhuan

Inventor after: Wang Xidi

Inventor before: Huang Shujuan

COR Change of bibliographic data
TR01 Transfer of patent right

Effective date of registration: 20160825

Address after: 262400 No. 323 Heng Heng street, Changle County, Shandong, Weifang

Patentee after: Nan Lingyan

Address before: B ultrasonic room, Wuhe County Hospital and 233300 Mo He Kou Zhen Anhui city of Bengbu Province

Patentee before: Huang Shujuan

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150121

Termination date: 20160731